These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29072804)

  • 1. Identification and Optimization of 4-Anilinoquinolines as Inhibitors of Cyclin G Associated Kinase.
    Asquith CRM; Laitinen T; Bennett JM; Godoi PH; East MP; Tizzard GJ; Graves LM; Johnson GL; Dornsife RE; Wells CI; Elkins JM; Willson TM; Zuercher WJ
    ChemMedChem; 2018 Jan; 13(1):48-66. PubMed ID: 29072804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and Analysis of the 4-Anilinoquin(az)oline Kinase Inhibition Profiles of GAK/SLK/STK10 Using Quantitative Structure-Activity Relationships.
    Asquith CRM; Laitinen T; Bennett JM; Wells CI; Elkins JM; Zuercher WJ; Tizzard GJ; Poso A
    ChemMedChem; 2020 Jan; 15(1):26-49. PubMed ID: 31675459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the Water Network in Cyclin G-Associated Kinase (GAK) with 4-Anilino-quin(az)oline Inhibitors.
    Asquith CRM; Tizzard GJ; Bennett JM; Wells CI; Elkins JM; Willson TM; Poso A; Laitinen T
    ChemMedChem; 2020 Jul; 15(13):1200-1215. PubMed ID: 32358915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of a Cyclin G Associated Kinase (GAK)/Epidermal Growth Factor Receptor (EGFR) Inhibitor Set to Interrogate the Relationship of EGFR and GAK in Chordoma.
    Asquith CRM; Naegeli KM; East MP; Laitinen T; Havener TM; Wells CI; Johnson GL; Drewry DH; Zuercher WJ; Morris DC
    J Med Chem; 2019 May; 62(9):4772-4778. PubMed ID: 30973735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a Potent Dual SLK/STK10 Inhibitor Based on a Maleimide Scaffold.
    Serafim RAM; Sorrell FJ; Berger BT; Collins RJ; Vasconcelos SNS; Massirer KB; Knapp S; Bennett J; Fedorov O; Patel H; Zuercher WJ; Elkins JM
    J Med Chem; 2021 Sep; 64(18):13259-13278. PubMed ID: 34463505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-Anilino-6-phenyl-quinoline inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK2).
    Olsson H; Sjö P; Ersoy O; Kristoffersson A; Larsson J; Nordén B
    Bioorg Med Chem Lett; 2010 Aug; 20(16):4738-40. PubMed ID: 20643547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of Isothiazolo[4,3- b]pyridine-Based Inhibitors of Cyclin G Associated Kinase (GAK) with Broad-Spectrum Antiviral Activity.
    Pu SY; Wouters R; Schor S; Rozenski J; Barouch-Bentov R; Prugar LI; O'Brien CM; Brannan JM; Dye JM; Herdewijn P; De Jonghe S; Einav S
    J Med Chem; 2018 Jul; 61(14):6178-6192. PubMed ID: 29953812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective Inhibitors of Cyclin G Associated Kinase (GAK) as Anti-Hepatitis C Agents.
    Kovackova S; Chang L; Bekerman E; Neveu G; Barouch-Bentov R; Chaikuad A; Heroven C; Šála M; De Jonghe S; Knapp S; Einav S; Herdewijn P
    J Med Chem; 2015 Apr; 58(8):3393-410. PubMed ID: 25822739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, biological evaluation and molecular modelling studies of 4-anilinoquinazoline derivatives as protein kinase inhibitors.
    Waiker DK; Karthikeyan C; Poongavanam V; Kongsted J; Lozach O; Meijer L; Trivedi P
    Bioorg Med Chem; 2014 Mar; 22(6):1909-15. PubMed ID: 24530227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of 3-phenyl- and 3-N-piperidinyl-isothiazolo[4,3-b]pyridines as highly potent inhibitors of cyclin G-associated kinase.
    Martinez-Gualda B; Saul S; Froeyen M; Schols D; Herdewijn P; Einav S; De Jonghe S
    Eur J Med Chem; 2021 Mar; 213():113158. PubMed ID: 33497888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AP-2-associated protein kinase 1 and cyclin G-associated kinase regulate hepatitis C virus entry and are potential drug targets.
    Neveu G; Ziv-Av A; Barouch-Bentov R; Berkerman E; Mulholland J; Einav S
    J Virol; 2015 Apr; 89(8):4387-404. PubMed ID: 25653444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and biological evaluation of 4-aniline-thieno[2,3-d]pyrimidine derivatives as MNK1 inhibitors against renal cell carcinoma and nasopharyngeal carcinoma.
    Zhang M; Jiang L; Tao J; Pan Z; He M; Su D; He G; Jiang Q
    Bioorg Med Chem; 2019 Jun; 27(11):2268-2279. PubMed ID: 31014565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gefitinib and luteolin cause growth arrest of human prostate cancer PC-3 cells via inhibition of cyclin G-associated kinase and induction of miR-630.
    Sakurai MA; Ozaki Y; Okuzaki D; Naito Y; Sasakura T; Okamoto A; Tabara H; Inoue T; Hagiyama M; Ito A; Yabuta N; Nojima H
    PLoS One; 2014; 9(6):e100124. PubMed ID: 24971999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Scaffold-Hopping Strategy toward the Identification of Inhibitors of Cyclin G Associated Kinase.
    Wouters R; Tian J; Herdewijn P; De Jonghe S
    ChemMedChem; 2019 Jan; 14(2):237-254. PubMed ID: 30548533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationship study of the pyridine moiety of isothiazolo[4,3-b]pyridines as antiviral agents targeting cyclin G-associated kinase.
    Martinez-Gualda B; Pu SY; Froeyen M; Herdewijn P; Einav S; De Jonghe S
    Bioorg Med Chem; 2020 Jan; 28(1):115188. PubMed ID: 31757682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tubercular activity of novel 4-anilinoquinolines and 4-anilinoquinazolines.
    Asquith CRM; Fleck N; Torrice CD; Crona DJ; Grundner C; Zuercher WJ
    Bioorg Med Chem Lett; 2019 Sep; 29(18):2695-2699. PubMed ID: 31378571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of novel 6-aryl substituted 4-anilinequinazoline derivatives as potential PI3Kδ inhibitors.
    Xin M; Hei YY; Zhang H; Shen Y; Zhang SQ
    Bioorg Med Chem Lett; 2017 May; 27(9):1972-1977. PubMed ID: 28325601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of isothiazolo[4,5-
    Ivanova Y; Spittaels S; Gao LJ; Schols D; Van Meervelt L; Froeyen M; Dehaen W; De Jonghe S
    Org Biomol Chem; 2024 Sep; 22(36):7373-7389. PubMed ID: 39171941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of a Selective and Potent Inhibitor of Mitogen-Activated Protein Kinase-Interacting Kinases 1 and 2 (MNK1/2) Utilizing Structure-Based Drug Design.
    Han W; Ding Y; Xu Y; Pfister K; Zhu S; Warne B; Doyle M; Aikawa M; Amiri P; Appleton B; Stuart DD; Fanidi A; Shafer CM
    J Med Chem; 2016 Apr; 59(7):3034-45. PubMed ID: 27002243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New pyrido[3,4-g]quinazoline derivatives as CLK1 and DYRK1A inhibitors: synthesis, biological evaluation and binding mode analysis.
    Tazarki H; Zeinyeh W; Esvan YJ; Knapp S; Chatterjee D; Schröder M; Joerger AC; Khiari J; Josselin B; Baratte B; Bach S; Ruchaud S; Anizon F; Giraud F; Moreau P
    Eur J Med Chem; 2019 Mar; 166():304-317. PubMed ID: 30731399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.